• レポートコード:QFJ1-4424 • 出版社/出版日:QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、108ページ • 納品方法:Eメール(納期:3日) • 産業分類:医療 |
Single User | ¥585,000 (USD3,900) | ▷ お問い合わせ |
Multi User | ¥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、LFAベース心臓マーカーの世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(トロポニン、CK-MB、ミオグロビン、その他)、用途別市場規模(臨床検査、ポイントオブケア検査)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。 ・市場概要 ・LFAベース心臓マーカーの市場動向 ・企業の競争状況、市場シェア ・LFAベース心臓マーカーの種類別市場規模と予測2016-2027(トロポニン、CK-MB、ミオグロビン、その他) ・LFAベース心臓マーカーの用途別市場規模と予測2016-2027(臨床検査、ポイントオブケア検査) ・LFAベース心臓マーカーの北米市場規模2016-2027(アメリカ、カナダ) ・LFAベース心臓マーカーの欧州市場規模2016-2027(ドイツ、フランス、イギリス等) ・LFAベース心臓マーカーのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・LFAベース心臓マーカーの中南米市場規模2016-2027(メキシコ、ブラジル) ・LFAベース心臓マーカーの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(Thermo Fisher、Bio-Rad Laboratories、Becton, Dickinson、Roche、Hologic、Abbott、Siemens、Danaher、Alere、BioMérieux、LSI、Clinical Diagnostics、Randox laboratories、Wondfo Biotech) ・結論 |
Market Analysis and Insights: Global LFA-based Cardiac Marker Market
The global LFA-based Cardiac Marker market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global LFA-based Cardiac Marker market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global LFA-based Cardiac Marker market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global LFA-based Cardiac Marker market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global LFA-based Cardiac Marker market.
Global LFA-based Cardiac Marker Scope and Market Size
LFA-based Cardiac Marker market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global LFA-based Cardiac Marker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Troponin
CK-MB
Myoglobin
Others
Segment by Application
Laboratory Testing
Point-of-care Testing
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Thermo Fisher
Bio-Rad Laboratories
Becton, Dickinson
Roche
Hologic
Abbott
Siemens
Danaher
Alere
BioMérieux
LSI
Clinical Diagnostics
Randox laboratories
Wondfo Biotech
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global LFA-based Cardiac Marker Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Troponin
1.2.3 CK-MB
1.2.4 Myoglobin
1.2.5 Others
1.3 Market by Application
1.3.1 Global LFA-based Cardiac Marker Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Laboratory Testing
1.3.3 Point-of-care Testing
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global LFA-based Cardiac Marker Market Perspective (2016-2027)
2.2 LFA-based Cardiac Marker Growth Trends by Regions
2.2.1 LFA-based Cardiac Marker Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 LFA-based Cardiac Marker Historic Market Share by Regions (2016-2021)
2.2.3 LFA-based Cardiac Marker Forecasted Market Size by Regions (2022-2027)
2.3 LFA-based Cardiac Marker Industry Dynamic
2.3.1 LFA-based Cardiac Marker Market Trends
2.3.2 LFA-based Cardiac Marker Market Drivers
2.3.3 LFA-based Cardiac Marker Market Challenges
2.3.4 LFA-based Cardiac Marker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top LFA-based Cardiac Marker Players by Revenue
3.1.1 Global Top LFA-based Cardiac Marker Players by Revenue (2016-2021)
3.1.2 Global LFA-based Cardiac Marker Revenue Market Share by Players (2016-2021)
3.2 Global LFA-based Cardiac Marker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by LFA-based Cardiac Marker Revenue
3.4 Global LFA-based Cardiac Marker Market Concentration Ratio
3.4.1 Global LFA-based Cardiac Marker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by LFA-based Cardiac Marker Revenue in 2020
3.5 LFA-based Cardiac Marker Key Players Head office and Area Served
3.6 Key Players LFA-based Cardiac Marker Product Solution and Service
3.7 Date of Enter into LFA-based Cardiac Marker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 LFA-based Cardiac Marker Breakdown Data by Type
4.1 Global LFA-based Cardiac Marker Historic Market Size by Type (2016-2021)
4.2 Global LFA-based Cardiac Marker Forecasted Market Size by Type (2022-2027)
5 LFA-based Cardiac Marker Breakdown Data by Application
5.1 Global LFA-based Cardiac Marker Historic Market Size by Application (2016-2021)
5.2 Global LFA-based Cardiac Marker Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America LFA-based Cardiac Marker Market Size (2016-2027)
6.2 North America LFA-based Cardiac Marker Market Size by Type
6.2.1 North America LFA-based Cardiac Marker Market Size by Type (2016-2021)
6.2.2 North America LFA-based Cardiac Marker Market Size by Type (2022-2027)
6.2.3 North America LFA-based Cardiac Marker Market Size by Type (2016-2027)
6.3 North America LFA-based Cardiac Marker Market Size by Application
6.3.1 North America LFA-based Cardiac Marker Market Size by Application (2016-2021)
6.3.2 North America LFA-based Cardiac Marker Market Size by Application (2022-2027)
6.3.3 North America LFA-based Cardiac Marker Market Size by Application (2016-2027)
6.4 North America LFA-based Cardiac Marker Market Size by Country
6.4.1 North America LFA-based Cardiac Marker Market Size by Country (2016-2021)
6.4.2 North America LFA-based Cardiac Marker Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe LFA-based Cardiac Marker Market Size (2016-2027)
7.2 Europe LFA-based Cardiac Marker Market Size by Type
7.2.1 Europe LFA-based Cardiac Marker Market Size by Type (2016-2021)
7.2.2 Europe LFA-based Cardiac Marker Market Size by Type (2022-2027)
7.2.3 Europe LFA-based Cardiac Marker Market Size by Type (2016-2027)
7.3 Europe LFA-based Cardiac Marker Market Size by Application
7.3.1 Europe LFA-based Cardiac Marker Market Size by Application (2016-2021)
7.3.2 Europe LFA-based Cardiac Marker Market Size by Application (2022-2027)
7.3.3 Europe LFA-based Cardiac Marker Market Size by Application (2016-2027)
7.4 Europe LFA-based Cardiac Marker Market Size by Country
7.4.1 Europe LFA-based Cardiac Marker Market Size by Country (2016-2021)
7.4.2 Europe LFA-based Cardiac Marker Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific LFA-based Cardiac Marker Market Size (2016-2027)
8.2 Asia-Pacific LFA-based Cardiac Marker Market Size by Type
8.2.1 Asia-Pacific LFA-based Cardiac Marker Market Size by Type (2016-2021)
8.2.2 Asia-Pacific LFA-based Cardiac Marker Market Size by Type (2022-2027)
8.2.3 Asia-Pacific LFA-based Cardiac Marker Market Size by Type (2016-2027)
8.3 Asia-Pacific LFA-based Cardiac Marker Market Size by Application
8.3.1 Asia-Pacific LFA-based Cardiac Marker Market Size by Application (2016-2021)
8.3.2 Asia-Pacific LFA-based Cardiac Marker Market Size by Application (2022-2027)
8.3.3 Asia-Pacific LFA-based Cardiac Marker Market Size by Application (2016-2027)
8.4 Asia-Pacific LFA-based Cardiac Marker Market Size by Region
8.4.1 Asia-Pacific LFA-based Cardiac Marker Market Size by Region (2016-2021)
8.4.2 Asia-Pacific LFA-based Cardiac Marker Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America LFA-based Cardiac Marker Market Size (2016-2027)
9.2 Latin America LFA-based Cardiac Marker Market Size by Type
9.2.1 Latin America LFA-based Cardiac Marker Market Size by Type (2016-2021)
9.2.2 Latin America LFA-based Cardiac Marker Market Size by Type (2022-2027)
9.2.3 Latin America LFA-based Cardiac Marker Market Size by Type (2016-2027)
9.3 Latin America LFA-based Cardiac Marker Market Size by Application
9.3.1 Latin America LFA-based Cardiac Marker Market Size by Application (2016-2021)
9.3.2 Latin America LFA-based Cardiac Marker Market Size by Application (2022-2027)
9.3.3 Latin America LFA-based Cardiac Marker Market Size by Application (2016-2027)
9.4 Latin America LFA-based Cardiac Marker Market Size by Country
9.4.1 Latin America LFA-based Cardiac Marker Market Size by Country (2016-2021)
9.4.2 Latin America LFA-based Cardiac Marker Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa LFA-based Cardiac Marker Market Size (2016-2027)
10.2 Middle East & Africa LFA-based Cardiac Marker Market Size by Type
10.2.1 Middle East & Africa LFA-based Cardiac Marker Market Size by Type (2016-2021)
10.2.2 Middle East & Africa LFA-based Cardiac Marker Market Size by Type (2022-2027)
10.2.3 Middle East & Africa LFA-based Cardiac Marker Market Size by Type (2016-2027)
10.3 Middle East & Africa LFA-based Cardiac Marker Market Size by Application
10.3.1 Middle East & Africa LFA-based Cardiac Marker Market Size by Application (2016-2021)
10.3.2 Middle East & Africa LFA-based Cardiac Marker Market Size by Application (2022-2027)
10.3.3 Middle East & Africa LFA-based Cardiac Marker Market Size by Application (2016-2027)
10.4 Middle East & Africa LFA-based Cardiac Marker Market Size by Country
10.4.1 Middle East & Africa LFA-based Cardiac Marker Market Size by Country (2016-2021)
10.4.2 Middle East & Africa LFA-based Cardiac Marker Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Details
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher LFA-based Cardiac Marker Introduction
11.1.4 Thermo Fisher Revenue in LFA-based Cardiac Marker Business (2016-2021)
11.1.5 Thermo Fisher Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Details
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories LFA-based Cardiac Marker Introduction
11.2.4 Bio-Rad Laboratories Revenue in LFA-based Cardiac Marker Business (2016-2021)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Becton, Dickinson
11.3.1 Becton, Dickinson Company Details
11.3.2 Becton, Dickinson Business Overview
11.3.3 Becton, Dickinson LFA-based Cardiac Marker Introduction
11.3.4 Becton, Dickinson Revenue in LFA-based Cardiac Marker Business (2016-2021)
11.3.5 Becton, Dickinson Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche LFA-based Cardiac Marker Introduction
11.4.4 Roche Revenue in LFA-based Cardiac Marker Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Hologic
11.5.1 Hologic Company Details
11.5.2 Hologic Business Overview
11.5.3 Hologic LFA-based Cardiac Marker Introduction
11.5.4 Hologic Revenue in LFA-based Cardiac Marker Business (2016-2021)
11.5.5 Hologic Recent Development
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott LFA-based Cardiac Marker Introduction
11.6.4 Abbott Revenue in LFA-based Cardiac Marker Business (2016-2021)
11.6.5 Abbott Recent Development
11.7 Siemens
11.7.1 Siemens Company Details
11.7.2 Siemens Business Overview
11.7.3 Siemens LFA-based Cardiac Marker Introduction
11.7.4 Siemens Revenue in LFA-based Cardiac Marker Business (2016-2021)
11.7.5 Siemens Recent Development
11.8 Danaher
11.8.1 Danaher Company Details
11.8.2 Danaher Business Overview
11.8.3 Danaher LFA-based Cardiac Marker Introduction
11.8.4 Danaher Revenue in LFA-based Cardiac Marker Business (2016-2021)
11.8.5 Danaher Recent Development
11.9 Alere
11.9.1 Alere Company Details
11.9.2 Alere Business Overview
11.9.3 Alere LFA-based Cardiac Marker Introduction
11.9.4 Alere Revenue in LFA-based Cardiac Marker Business (2016-2021)
11.9.5 Alere Recent Development
11.10 BioMérieux
11.10.1 BioMérieux Company Details
11.10.2 BioMérieux Business Overview
11.10.3 BioMérieux LFA-based Cardiac Marker Introduction
11.10.4 BioMérieux Revenue in LFA-based Cardiac Marker Business (2016-2021)
11.10.5 BioMérieux Recent Development
11.11 LSI
11.11.1 LSI Company Details
11.11.2 LSI Business Overview
11.11.3 LSI LFA-based Cardiac Marker Introduction
11.11.4 LSI Revenue in LFA-based Cardiac Marker Business (2016-2021)
11.11.5 LSI Recent Development
11.12 Clinical Diagnostics
11.12.1 Clinical Diagnostics Company Details
11.12.2 Clinical Diagnostics Business Overview
11.12.3 Clinical Diagnostics LFA-based Cardiac Marker Introduction
11.12.4 Clinical Diagnostics Revenue in LFA-based Cardiac Marker Business (2016-2021)
11.12.5 Clinical Diagnostics Recent Development
11.13 Randox laboratories
11.13.1 Randox laboratories Company Details
11.13.2 Randox laboratories Business Overview
11.13.3 Randox laboratories LFA-based Cardiac Marker Introduction
11.13.4 Randox laboratories Revenue in LFA-based Cardiac Marker Business (2016-2021)
11.13.5 Randox laboratories Recent Development
11.14 Wondfo Biotech
11.14.1 Wondfo Biotech Company Details
11.14.2 Wondfo Biotech Business Overview
11.14.3 Wondfo Biotech LFA-based Cardiac Marker Introduction
11.14.4 Wondfo Biotech Revenue in LFA-based Cardiac Marker Business (2016-2021)
11.14.5 Wondfo Biotech Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global LFA-based Cardiac Marker Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Troponin
Table 3. Key Players of CK-MB
Table 4. Key Players of Myoglobin
Table 5. Key Players of Others
Table 6. Global LFA-based Cardiac Marker Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global LFA-based Cardiac Marker Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global LFA-based Cardiac Marker Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global LFA-based Cardiac Marker Market Share by Regions (2016-2021)
Table 10. Global LFA-based Cardiac Marker Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global LFA-based Cardiac Marker Market Share by Regions (2022-2027)
Table 12. LFA-based Cardiac Marker Market Trends
Table 13. LFA-based Cardiac Marker Market Drivers
Table 14. LFA-based Cardiac Marker Market Challenges
Table 15. LFA-based Cardiac Marker Market Restraints
Table 16. Global LFA-based Cardiac Marker Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global LFA-based Cardiac Marker Market Share by Players (2016-2021)
Table 18. Global Top LFA-based Cardiac Marker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in LFA-based Cardiac Marker as of 2020)
Table 19. Ranking of Global Top LFA-based Cardiac Marker Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by LFA-based Cardiac Marker Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players LFA-based Cardiac Marker Product Solution and Service
Table 23. Date of Enter into LFA-based Cardiac Marker Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global LFA-based Cardiac Marker Market Size by Type (2016-2021) (US$ Million)
Table 26. Global LFA-based Cardiac Marker Revenue Market Share by Type (2016-2021)
Table 27. Global LFA-based Cardiac Marker Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global LFA-based Cardiac Marker Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global LFA-based Cardiac Marker Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global LFA-based Cardiac Marker Revenue Market Share by Application (2016-2021)
Table 31. Global LFA-based Cardiac Marker Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global LFA-based Cardiac Marker Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America LFA-based Cardiac Marker Market Size by Type (2016-2021) (US$ Million)
Table 34. North America LFA-based Cardiac Marker Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America LFA-based Cardiac Marker Market Size by Application (2016-2021) (US$ Million)
Table 36. North America LFA-based Cardiac Marker Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America LFA-based Cardiac Marker Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America LFA-based Cardiac Marker Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe LFA-based Cardiac Marker Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe LFA-based Cardiac Marker Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe LFA-based Cardiac Marker Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe LFA-based Cardiac Marker Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe LFA-based Cardiac Marker Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe LFA-based Cardiac Marker Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific LFA-based Cardiac Marker Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific LFA-based Cardiac Marker Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific LFA-based Cardiac Marker Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific LFA-based Cardiac Marker Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific LFA-based Cardiac Marker Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific LFA-based Cardiac Marker Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America LFA-based Cardiac Marker Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America LFA-based Cardiac Marker Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America LFA-based Cardiac Marker Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America LFA-based Cardiac Marker Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America LFA-based Cardiac Marker Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America LFA-based Cardiac Marker Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa LFA-based Cardiac Marker Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa LFA-based Cardiac Marker Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa LFA-based Cardiac Marker Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa LFA-based Cardiac Marker Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa LFA-based Cardiac Marker Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa LFA-based Cardiac Marker Market Size by Country (2022-2027) & (US$ Million)
Table 63. Thermo Fisher Company Details
Table 64. Thermo Fisher Business Overview
Table 65. Thermo Fisher LFA-based Cardiac Marker Product
Table 66. Thermo Fisher Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million)
Table 67. Thermo Fisher Recent Development
Table 68. Bio-Rad Laboratories Company Details
Table 69. Bio-Rad Laboratories Business Overview
Table 70. Bio-Rad Laboratories LFA-based Cardiac Marker Product
Table 71. Bio-Rad Laboratories Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million)
Table 72. Bio-Rad Laboratories Recent Development
Table 73. Becton, Dickinson Company Details
Table 74. Becton, Dickinson Business Overview
Table 75. Becton, Dickinson LFA-based Cardiac Marker Product
Table 76. Becton, Dickinson Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million)
Table 77. Becton, Dickinson Recent Development
Table 78. Roche Company Details
Table 79. Roche Business Overview
Table 80. Roche LFA-based Cardiac Marker Product
Table 81. Roche Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million)
Table 82. Roche Recent Development
Table 83. Hologic Company Details
Table 84. Hologic Business Overview
Table 85. Hologic LFA-based Cardiac Marker Product
Table 86. Hologic Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million)
Table 87. Hologic Recent Development
Table 88. Abbott Company Details
Table 89. Abbott Business Overview
Table 90. Abbott LFA-based Cardiac Marker Product
Table 91. Abbott Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million)
Table 92. Abbott Recent Development
Table 93. Siemens Company Details
Table 94. Siemens Business Overview
Table 95. Siemens LFA-based Cardiac Marker Product
Table 96. Siemens Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million)
Table 97. Siemens Recent Development
Table 98. Danaher Company Details
Table 99. Danaher Business Overview
Table 100. Danaher Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million)
Table 101. Danaher Recent Development
Table 102. Alere Company Details
Table 103. Alere Business Overview
Table 104. Alere LFA-based Cardiac Marker Product
Table 105. Alere Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million)
Table 106. Alere Recent Development
Table 107. BioMérieux Company Details
Table 108. BioMérieux Business Overview
Table 109. BioMérieux LFA-based Cardiac Marker Product
Table 110. BioMérieux Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million)
Table 111. BioMérieux Recent Development
Table 112. LSI Company Details
Table 113. LSI Business Overview
Table 114. LSI LFA-based Cardiac Marker Product
Table 115. LSI Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million)
Table 116. LSI Recent Development
Table 117. Clinical Diagnostics Company Details
Table 118. Clinical Diagnostics Business Overview
Table 119. Clinical Diagnostics LFA-based Cardiac Marker Product
Table 120. Clinical Diagnostics Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million)
Table 121. Clinical Diagnostics Recent Development
Table 122. Randox laboratories Company Details
Table 123. Randox laboratories Business Overview
Table 124. Randox laboratories LFA-based Cardiac Marker Product
Table 125. Randox laboratories Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million)
Table 126. Randox laboratories Recent Development
Table 127. Wondfo Biotech Company Details
Table 128. Wondfo Biotech Business Overview
Table 129. Wondfo Biotech LFA-based Cardiac Marker Product
Table 130. Wondfo Biotech Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million)
Table 131. Wondfo Biotech Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global LFA-based Cardiac Marker Market Share by Type: 2020 VS 2027
Figure 2. Troponin Features
Figure 3. CK-MB Features
Figure 4. Myoglobin Features
Figure 5. Others Features
Figure 6. Global LFA-based Cardiac Marker Market Share by Application: 2020 VS 2027
Figure 7. Laboratory Testing Case Studies
Figure 8. Point-of-care Testing Case Studies
Figure 9. LFA-based Cardiac Marker Report Years Considered
Figure 10. Global LFA-based Cardiac Marker Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global LFA-based Cardiac Marker Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global LFA-based Cardiac Marker Market Share by Regions: 2020 VS 2027
Figure 13. Global LFA-based Cardiac Marker Market Share by Regions (2022-2027)
Figure 14. Global LFA-based Cardiac Marker Market Share by Players in 2020
Figure 15. Global Top LFA-based Cardiac Marker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in LFA-based Cardiac Marker as of 2020
Figure 16. The Top 10 and 5 Players Market Share by LFA-based Cardiac Marker Revenue in 2020
Figure 17. Global LFA-based Cardiac Marker Revenue Market Share by Type (2016-2021)
Figure 18. Global LFA-based Cardiac Marker Revenue Market Share by Type (2022-2027)
Figure 19. North America LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America LFA-based Cardiac Marker Market Share by Type (2016-2027)
Figure 21. North America LFA-based Cardiac Marker Market Share by Application (2016-2027)
Figure 22. North America LFA-based Cardiac Marker Market Share by Country (2016-2027)
Figure 23. United States LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe LFA-based Cardiac Marker Market Share by Type (2016-2027)
Figure 27. Europe LFA-based Cardiac Marker Market Share by Application (2016-2027)
Figure 28. Europe LFA-based Cardiac Marker Market Share by Country (2016-2027)
Figure 29. Germany LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific LFA-based Cardiac Marker Market Share by Type (2016-2027)
Figure 37. Asia-Pacific LFA-based Cardiac Marker Market Share by Application (2016-2027)
Figure 38. Asia-Pacific LFA-based Cardiac Marker Market Share by Region (2016-2027)
Figure 39. China LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America LFA-based Cardiac Marker Market Share by Type (2016-2027)
Figure 47. Latin America LFA-based Cardiac Marker Market Share by Application (2016-2027)
Figure 48. Latin America LFA-based Cardiac Marker Market Share by Country (2016-2027)
Figure 49. Mexico LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa LFA-based Cardiac Marker Market Share by Type (2016-2027)
Figure 53. Middle East & Africa LFA-based Cardiac Marker Market Share by Application (2016-2027)
Figure 54. Middle East & Africa LFA-based Cardiac Marker Market Share by Country (2016-2027)
Figure 55. Turkey LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Thermo Fisher Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021)
Figure 59. Bio-Rad Laboratories Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021)
Figure 60. Becton, Dickinson Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021)
Figure 62. Hologic Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021)
Figure 63. Abbott Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021)
Figure 64. Siemens Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021)
Figure 65. Danaher Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021)
Figure 66. Alere Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021)
Figure 67. BioMérieux Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021)
Figure 68. LSI Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021)
Figure 69. Clinical Diagnostics Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021)
Figure 70. Randox laboratories Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021)
Figure 71. Wondfo Biotech Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed